Australia markets closed

ENTA Oct 2024 12.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.75000.0000 (0.00%)
As of 11:26AM EDT. Market open.
Full screen
Previous close1.7500
Open1.7500
Bid0.9500
Ask2.5000
Strike12.50
Expiry date2024-10-18
Day's range1.7500 - 1.7500
Contract rangeN/A
Volume1
Open interest1
  • Business Wire

    Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference

    WATERTOWN, Mass., May 29, 2024--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2024 at 7:30 a.m. ET in New York, NY.

  • Simply Wall St.

    Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

    Enanta Pharmaceuticals ( NASDAQ:ENTA ) Second Quarter 2024 Results Key Financial Results Revenue: US$17.1m (down 4.2...

  • Insider Monkey

    Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript

    Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript May 6, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Enanta Pharmaceuticals’ Fiscal Second Quarter Financial Results Conference Call. At this time, […]